Canada Proposes THC-based Tax Rate for Edibles in 2019 Budget

The Canadian federal government proposed in its 2019 budget a new tax rate for incoming edible products based on THC levels.

As the Canadian federal government releases its budget plan for the year, the marijuana industry is reacting to new taxes for upcoming products.

On Tuesday (March 19), the Liberal government tabled its 2019 budget; in it, a few cannabis reforms attracted the attention of the market.

Based on recommendations from the cannabis task force set up en route to legalization in 2018, the government is proposing a tetrahydrocannabinol-based (THC) tax rate for the incoming edible and topical products.

The new system will be implemented starting in May and, according to the government, will not affect the already designated revenue-sharing deals with “most provincial and territorial governments.”

The government made it clear that existing legal products such as dried flower, seeds and seedlings will see no changes to their current excise-duty framework.

As a way to “alleviate compliance issues that producers have encountered with respect to the tracking of the quantity of cannabis material contained in cannabis oils,” the government is proposing this system for the new products.

In the final document, the government indicated:

“Budget 2019 proposes that edible cannabis, cannabis extracts (including cannabis oils) and cannabis topicals be subject to excise duties imposed on cannabis licensees at a flat rate applied on the quantity of total tetrahydrocannabinol (THC), the primary psychoactive compound in cannabis, contained in a final product.”

As indicated by the Cannabis Act, marijuana edibles, extracts and other topical products are set to be legalized this year on or before October 17.

Terry Lake, the vice president of corporate and social responsibility with licensed producer Hexo (NYSEAMERICAN:HEXO,TSX:HEXO), tweeted his support for the tax on THC items, saying it “makes for good public health policy.”

However, the former BC minister of health signaled this would represent another cost for patients who need high-THC products.

Several advocates, including executives in marijuana companies and associations such as Canadians for Fair Access to Medical Marijuana (CFAMM), have called out the government for its initial taxing system on medical cannabis.

In a message to supporters, CFAMM said the association is “disappointed” in the government’s decision to include sales and excise taxes on medical cannabis as part of its new budget.

Emerald Health Therapeutics (TSXV:EMH,OTCQX:EMHTF) issued an update to shareholders announcing that this tax could improve its profit margins on some of its hemp products.

“We believe that the federal government’s recommendation to revise the cannabis excise tax will reduce taxes on the low-THC products Emerald intends to produce from its contracted hemp harvest for medical use,” Avtar Dhillon, president and executive chairman of the firm, said in a press release.

“We expect that this proposed revision to the excise tax calculation will enhance our opportunity to utilize our purchased hemp in an economically viable way as feedstock for new cannabinoid-containing ingestible products,” he added.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Featured
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors ofCronos Group Inc. for violations of the securities lawsThe investigation focuses on whether the Company issued false andor misleading statements andor failed to disclose information pertinent to investors. Cronos filed a Form 8-K with the SEC on November 9, 2021, disclosing that the ...

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors ofCronos Group Inc. ("Cronos" or "the Company") (NASDAQ:CRON) for violations of the securities laws

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Cronos filed a Form 8-K with the SEC on November 9, 2021, disclosing that the Company would "be required to restate its previously issued unaudited interim financial statements for the three and six months ended June 30, 2021" and that "the Company's financial statements for this period should therefore no longer be relied upon." Based on this news, shares of Cronos fell by nearly 16%.

read more Show less
The company's first ESG report outlines efforts to operate with integrity and support long-term sustainability Trulieve Cannabis Corp. the largest multi-state operator in the United States today announced the publication of its first Environmental, Social, and Governance Report . The Report contains standard disclosures from the Global Reporting Initiative Sustainability Reporting Standards, The Sustainability ...

The company's first ESG report outlines efforts to operate with integrity and support
long-term sustainability

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), the largest multi-state operator (MSO) in the United States today announced the publication of its first Environmental, Social, and Governance (ESG) Report (the "Report"). The Report contains standard disclosures from the Global Reporting Initiative (GRI) Sustainability Reporting Standards, The Sustainability Accounting Standards Board (SASB) as well as the United Nations Sustainable Development Goals. The Report highlights ESG achievements to date and serves as a foundation for demonstrating how the Company's ESG approach, strategies and commitments are embedded within its core business.

read more Show less
Pomerantz LLP is investigating claims on behalf of investors of Cronos Group Inc. . Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.The investigation concerns whether Cronos and certain of its officers andor directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class action] On ...

Pomerantz LLP is investigating claims on behalf of investors of Cronos Group Inc. ("Cronos" or the "Company") (NASDAQ: CRON). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.

The investigation concerns whether Cronos and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

read more Show less

MARKETS

Markets
TSX21194.19+68.29
TSXV952.60+8.55
DOW35195.69+296.35
S&P 5004665.58+70.96
NASD15809.18+317.52
ASX7279.30-128.00

COMMODITIES

Commodities
Gold1782.12-13.13
Silver22.78-0.52
Copper4.34+0.05
Palladium1791.50+7.00
Platinum958.58-21.43
Oil69.48+1.33
Heating Oil2.14+0.05
Natural Gas4.84-0.63